D-Index & Metrics Best Publications
Research.com 2022 Best Female Scientist Award Badge

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 103 Citations 35,567 384 World Ranking 3277 National Ranking 1879
Best female scientists D-index 105 Citations 36,926 499 World Ranking 717 National Ranking 443

Research.com Recognitions

Awards & Achievements

2022 - Research.com Best Female Scientist Award

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Gene
  • Internal medicine

Stefania Pittaluga focuses on Lymphoma, Pathology, Immunology, Cancer research and Internal medicine. Stefania Pittaluga regularly ties together related areas like Germinal center in her Lymphoma studies. Her Pathology research includes themes of Fluorescence in situ hybridization, Gene rearrangement, Cancer and Cytogenetics.

The Immunology study combines topics in areas such as Hematopoietic stem cell transplantation, Transplantation and Haploinsufficiency. Her work carried out in the field of Cancer research brings together such families of science as Mutation, B cell, Signal transduction, Cyclin D3 and breakpoint cluster region. Her studies in Internal medicine integrate themes in fields like Vascular endothelial growth factor C and Oncology.

Her most cited work include:

  • Gene-Expression Profiles in Hereditary Breast Cancer (1546 citations)
  • Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (647 citations)
  • The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia (637 citations)

What are the main themes of her work throughout her whole career to date?

Stefania Pittaluga mainly investigates Pathology, Lymphoma, Immunology, Internal medicine and Cancer research. Stefania Pittaluga works mostly in the field of Pathology, limiting it down to topics relating to Gene rearrangement and, in certain cases, Molecular biology, as a part of the same area of interest. Her Lymphoma research incorporates themes from Epstein–Barr virus and Germinal center.

Her studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine. Her Cancer research research also works with subjects such as

  • Chronic lymphocytic leukemia that intertwine with fields like Bone marrow,
  • breakpoint cluster region which is related to area like Ibrutinib. The study incorporates disciplines such as Vincristine and Etoposide in addition to Rituximab.

She most often published in these fields:

  • Pathology (35.51%)
  • Lymphoma (35.31%)
  • Immunology (25.71%)

What were the highlights of her more recent work (between 2018-2021)?

  • Lymphoma (35.31%)
  • Internal medicine (23.06%)
  • Cancer research (21.43%)

In recent papers she was focusing on the following fields of study:

Her primary areas of study are Lymphoma, Internal medicine, Cancer research, Immunology and Oncology. Her Lymphoma study results in a more complete grasp of Pathology. Her biological study spans a wide range of topics, including Diffuse alveolar damage and Chronic lymphocytic leukemia.

Her Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology. Her Cancer research research is multidisciplinary, relying on both Downregulation and upregulation, Germinal center, High grade B-cell lymphoma, Antigen and Follicular lymphoma. The concepts of her Oncology study are interwoven with issues in Lenalidomide, Cytarabine, Ibrutinib, Febrile neutropenia and Prednisone.

Between 2018 and 2021, her most popular works were:

  • Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series. (228 citations)
  • SARS-CoV-2 infection of the oral cavity and saliva. (81 citations)
  • Insights into pathogenesis of fatal COVID-19 pneumonia from histopathology with immunohistochemical and viral RNA studies. (46 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Internal medicine

Stefania Pittaluga focuses on Immunology, Lymphoma, Cancer research, Internal medicine and Virus. Her Immunology study frequently draws connections between related disciplines such as Saliva. Many of her research projects under Lymphoma are closely connected to Context with Context, tying the diverse disciplines of science together.

Her Cancer research study combines topics in areas such as Mutation, Histiocytosis, Adult female and Oncogene Proteins. The various areas that Stefania Pittaluga examines in her Internal medicine study include Gastroenterology and Oncology. Her Virus study combines topics from a wide range of disciplines, such as Myeloid, Complement factor B, Complement system and Pneumonia.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Gene-Expression Profiles in Hereditary Breast Cancer

I Hedenfalk;D Duggan;Y Chen;M Radmacher.
The New England Journal of Medicine (2001)

2078 Citations

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Yair Herishanu;Patricia Pérez-Galán;Delong Liu;Angélique Biancotto.
Blood (2011)

837 Citations

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang.
Nature Medicine (2015)

782 Citations

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar.
Nature (2012)

748 Citations

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

Roland Schmitz;George W. Wright;Da Wei Huang;Calvin A. Johnson.
The New England Journal of Medicine (2018)

658 Citations

Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma

Kieron Dunleavy;Stefania Pittaluga;Myron S. Czuczman;Sandeep S. Dave.
Blood (2009)

656 Citations

Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

Hye Sun Kuehn;Weiming Ouyang;Bernice Lo;Elissa K. Deenick;Elissa K. Deenick.
Science (2014)

548 Citations

Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.

Lluís Colomo;Florence Loong;Susana Rives;Stefania Pittaluga.
The American Journal of Surgical Pathology (2004)

488 Citations

Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1

Ombretta Salvucci;Lei Yao;Sabrina Villalba;Agatha Sajewicz.
Blood (2002)

477 Citations

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome

Amy P. Hsu;Elizabeth P. Sampaio;Javed Khan;Katherine R. Calvo.
Blood (2011)

476 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Stefania Pittaluga

Elias Campo

Elias Campo

University of Barcelona

Publications: 154

Elaine S. Jaffe

Elaine S. Jaffe

National Institutes of Health

Publications: 124

L. Jeffrey Medeiros

L. Jeffrey Medeiros

The University of Texas MD Anderson Cancer Center

Publications: 111

Randy D. Gascoyne

Randy D. Gascoyne

BC Cancer Agency

Publications: 98

Andreas Rosenwald

Andreas Rosenwald

University of Würzburg

Publications: 94

Wolfram Klapper

Wolfram Klapper

Kiel University

Publications: 86

Stuart G. Tangye

Stuart G. Tangye

Garvan Institute of Medical Research

Publications: 83

Wyndham H. Wilson

Wyndham H. Wilson

National Institutes of Health

Publications: 82

Reiner Siebert

Reiner Siebert

University of Ulm

Publications: 79

German Ott

German Ott

Robert Bosch (Germany)

Publications: 78

Louis M. Staudt

Louis M. Staudt

National Institutes of Health

Publications: 76

Shigeo Nakamura

Shigeo Nakamura

Nagoya University

Publications: 76

Gilles Salles

Gilles Salles

Memorial Sloan Kettering Cancer Center

Publications: 72

Jean-Laurent Casanova

Jean-Laurent Casanova

Rockefeller University

Publications: 71

Jan A. Burger

Jan A. Burger

The University of Texas MD Anderson Cancer Center

Publications: 70

Stefano Pileri

Stefano Pileri

European Institute of Oncology

Publications: 69

Trending Scientists

Per Runeson

Per Runeson

Lund University

Roberto Verganti

Roberto Verganti

Polytechnic University of Milan

Ashok Kumar Pradhan

Ashok Kumar Pradhan

Indian Institute of Technology Kharagpur

Junfeng Fang

Junfeng Fang

East China Normal University

Keat Ghee Ong

Keat Ghee Ong

University of Oregon

Tae-Woo Lee

Tae-Woo Lee

Seoul National University

David M. Bodine

David M. Bodine

National Institutes of Health

Jonathan R. Pollack

Jonathan R. Pollack

Stanford University

Stuart Black

Stuart Black

University of Reading

Per Schjønning

Per Schjønning

Aarhus University

James M. Brewer

James M. Brewer

University of Glasgow

Eckhard R. Podack

Eckhard R. Podack

University of Miami

Graham Dunn

Graham Dunn

University of Manchester

Aman U. Buzdar

Aman U. Buzdar

The University of Texas at Austin

Martin S. Tallman

Martin S. Tallman

Memorial Sloan Kettering Cancer Center

Mark I. Wilkinson

Mark I. Wilkinson

University of Edinburgh

Something went wrong. Please try again later.